Cidara Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €495.01M +126.9% €117.36M -468.8% 23.7% +0.38 pp N/A N/A
    (estimated) €218.12M +2,847.2% -€31.82M -80.9% -14.6% +22 pp N/A N/A
    (estimated) €7.40M +33.2% -€166.20M +6.1% -2,245.7% +5.7 pp -€94.88M -42.7% -1,282.1% +17 pp
    (estimated) €5.56M +∞% -€156.58M +55.7% -2,818.6% -28 pp -€165.62M +82.9% -2,981.4% -30 pp
    (estimated) €0.00 -100.0% -€100.53M -31.4% N/A -€90.57M -40.5% N/A
    €1.10M -98.0% -€146.49M +640.6% -13,319.8% -130 pp -€152.16M +704.5% -13,835.6% -140 pp
    €55.12M -0.6% -€19.78M -23.0% -35.9% +0.10 pp -€18.91M -22.7% -34.3% +0.098 pp
    €55.45M +29.7% -€25.70M -32.1% -46.4% +0.42 pp -€24.46M +12.6% -44.1% +0.067 pp
    €42.76M +310.8% -€37.88M -39.3% -88.6% +5.1 pp -€21.73M -53.5% -50.8% +4.0 pp
    €10.41M -42.3% -€62.43M +80.5% -599.8% -4.1 pp -€46.77M +90.3% -449.4% -3.1 pp
    €18.04M +∞% -€34.58M -32.1% -191.7% -1.9 pp -€24.58M -49.6% -136.3% -1.4 pp
    €0.00 +NaN% -€50.91M +5.9% N/A -€48.76M +14.0% N/A
    €0.00 +NaN% -€48.07M +15.7% N/A -€42.79M +26.0% N/A
    €0.00 +NaN% -€41.55M +49.6% N/A -€33.96M +58.8% N/A
    €0.00 +NaN% -€27.77M +170.7% N/A -€21.38M +268.9% N/A
    €0.00 +NaN% -€10.26M +785.0% N/A -€5.80M +541.1% N/A
    €0.00 +NaN% -€1.16M +69.7% N/A -€903.99K -∞% N/A
    €0.00 -€683.17K N/A €0.00 N/A

    Notifications